Postnatal loss of methyl-CpG binding protein 2 in the Forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice

被引:176
作者
Gemelli, T
Berton, O
Nelson, ED
Perrotti, LI
Jaenisch, R
Monteggia, LM
机构
[1] Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA
[2] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA
关键词
MeCP2; Rett syndrome; knockout; behavior; animal model;
D O I
10.1016/j.biopsych.2005.07.025
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Mutations in the methyl-CpG binding protein 2 (MeCP2) gene cause Rett syndrome (RTT), a neurodevelopmental disorder that is accompanied by a broad array of behavioral phenotypes, mainly affecting females. Methyl-CpG binding protein 2 is a transcriptional repressor that is widely expressed in all tissues. To investigate whether the postnatal loss of MeCP2 in the forebrain is sufficient to produce the behavioral phenotypes observed in RTT, we have generated conditional MeCP2 knockout mice. These mice display behavioral abnormailities similar to RTT phenotypes, including hindlimb clasping, impaired motor coordination, increased anxiety, and abnormal social behavior with other mice. These mice, however, have normal locomotor activity and unimpaired context-dependent fear conditioning, suggesting that the behavioral deficits observed are the result of loss of MeCP2 function in postnatal forebrain and not the result of generalized global deficits. These data highlight the important role of MeCP2 in the forebrain and suggest that even partial loss of MeCP2 expression in these brain regions is sufficient to recapitulate features of RTT.
引用
收藏
页码:468 / 476
页数:9
相关论文
共 26 条
[1]   Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 [J].
Amir, RE ;
Van den Veyver, IB ;
Wan, M ;
Tran, CQ ;
Francke, U ;
Zoghbi, HY .
NATURE GENETICS, 1999, 23 (02) :185-188
[2]  
Amir RE, 2000, ANN NEUROL, V47, P670, DOI 10.1002/1531-8249(200005)47:5<670::AID-ANA20>3.0.CO
[3]  
2-F
[4]   The HD mutation causes progressive lethal neurological disease in mice expressing reduced levels of huntingtin [J].
Auerbach, W ;
Hurlbert, MS ;
Hilditch-Maguire, P ;
Wadghiri, YZ ;
Wheeler, VC ;
Cohen, SI ;
Joyner, AL ;
MacDonald, ME ;
Turnbull, DH .
HUMAN MOLECULAR GENETICS, 2001, 10 (22) :2515-2523
[5]   Effects of Rett syndrome mutations of the methyl-CpG binding domain of the transcriptional repressor MeCP2 on selectivity for association with methylated DNA [J].
Ballestar, E ;
Yusufzai, TM ;
Wolffe, AP .
BIOCHEMISTRY, 2000, 39 (24) :7100-7106
[6]   MECP2 mutations account for most cases of typical forms of Rett syndrome [J].
Bienvenu, T ;
Carrié, A ;
de Roux, N ;
Vinet, MC ;
Jonveaux, P ;
Couvert, P ;
Villard, L ;
Arzimanoglou, A ;
Beldjord, C ;
Fontes, M ;
Tardieu, M ;
Chelly, J .
HUMAN MOLECULAR GENETICS, 2000, 9 (09) :1377-1384
[7]   Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice [J].
Chen, RZ ;
Akbarian, S ;
Tudor, M ;
Jaenisch, R .
NATURE GENETICS, 2001, 27 (03) :327-331
[8]   Mild overexpression of MeCP2 causes a progressive neurological disorder in mice [J].
Collins, AL ;
Levenson, JM ;
Vilaythong, AP ;
Richman, R ;
Armstrong, DL ;
Noebels, JL ;
Sweatt, JD ;
Zoghbi, HY .
HUMAN MOLECULAR GENETICS, 2004, 13 (21) :2679-2689
[9]   Early degenerative changes in transgenic mice expressing mutant huntingtin involve dendritic abnormalities but no impairment of mitochondrial energy production [J].
Guidetti, P ;
Charles, V ;
Chen, EY ;
Reddy, PH ;
Kordower, JH ;
Whetsell, WO ;
Schwarcz, R ;
Tagle, DA .
EXPERIMENTAL NEUROLOGY, 2001, 169 (02) :340-350
[10]   A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome [J].
Guy, J ;
Hendrich, B ;
Holmes, M ;
Martin, JE ;
Bird, A .
NATURE GENETICS, 2001, 27 (03) :322-326